Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes

Science Translational Medicine
Miao WangDefu Zeng

Abstract

Type 1 diabetes (T1D) results from an autoimmune destruction of insulin-producing β cells. Currently, islet transplantation is the only curative therapy for late-stage T1D, but the beneficial effect is limited in its duration, even under chronic immunosuppression, because of the chronic graft rejection mediated by both auto- and alloimmunity. Clinical islet transplantation is also restricted by a severe shortage of donor islets. Induction of mixed chimerism reverses autoimmunity, eliminates insulitis, and reverses new-onset but not late-stage disease in the nonobese diabetic (NOD) mouse model of T1D. Administration of gastrin and epidermal growth factor (EGF) also reverses new-onset but not late-stage T1D in this animal model. Here, we showed that combination therapy of induced mixed chimerism under a radiation-free nontoxic anti-CD3/CD8 conditioning regimen and administration of gastrin/EGF augments both β cell neogenesis and replication, resulting in reversal of late-stage T1D in NOD mice. If successfully translated into humans, this combination therapy could replace islet transplantation as a long-term curative therapy for T1D.

References

Jan 1, 1990·Annual Review of Immunology·L Castaño, G S Eisenbarth
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·L ChatenoudJ F Bach
Sep 17, 2005·The Journal of Clinical Investigation·Brygida BisikirskaKevan C Herold
Apr 22, 2006·The Journal of Clinical Investigation·Damien BressonMatthias von Herrath
Sep 29, 2006·The New England Journal of Medicine·A M James ShapiroJonathan R T Lakey
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Chunyan ZhangDefu Zeng
Jan 25, 2008·The New England Journal of Medicine·John D ScandlingSamuel Strober
Mar 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Nainong LiDefu Zeng
Aug 30, 2008·Nature·Qiao ZhouDouglas A Melton
Oct 3, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·P FiorinaA Secchi
Dec 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Akari InadaSusan Bonner-Weir
Nov 27, 2009·The New England Journal of Medicine·Mark D PescovitzUNKNOWN Type 1 Diabetes TrialNet Anti-CD20 Study Group
Jan 12, 2010·The Journal of Clinical Endocrinology and Metabolism·Philippe A HalbanGordon C Weir
Aug 13, 2011·Science Translational Medicine·Kevan C Herold, Jeffrey A Bluestone

❮ Previous
Next ❯

Citations

Mar 13, 2013·Nature Reviews. Endocrinology·Sharon A Sadry, Daniel J Drucker
May 11, 2012·Science Translational Medicine·Anita S Chong, Graeme I Bell
Sep 12, 2013·PloS One·Christian W GrantLisa M Spain
Jul 6, 2014·Diabetologia·Yi-Chun ChenPatrick T Fueger
Jan 7, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mingfeng ZhangDefu Zeng
Dec 10, 2015·Proceedings of the National Academy of Sciences of the United States of America·Limin WuDefu Zeng
Apr 11, 2017·Clinical and Experimental Immunology·B Mahr, T Wekerle
Feb 22, 2018·Proceedings of the National Academy of Sciences of the United States of America·Mingfeng ZhangDefu Zeng
Aug 20, 2016·Therapeutic Advances in Endocrinology and Metabolism·Elisa CorritorePhilippe A Lysy
Apr 11, 2013·Stem Cells Translational Medicine·Preeti Chhabra, Kenneth L Brayman
Nov 28, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeremy J RacineDefu Zeng
Jul 9, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Miao WangDefu Zeng
Sep 18, 2013·Diabetes, Obesity & Metabolism·L DingC Mathieu
Aug 21, 2020·The Journal of Clinical Investigation·Yuqing LiuDefu Zeng
Nov 25, 2020·Proceedings of the National Academy of Sciences of the United States of America·Shanshan TangDefu Zeng
Nov 29, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Claresa S Levetan, Susan M Pierce
Dec 16, 2019·Drug Discovery Today·Labe Black, Tatiana Zorina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.